Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01133119Phase 2Completed
Phase 2, randomised, open-label trial in pain comparing Standard of Care with Bupivacaine (2 arms). Primary endpoint: Self-reported levels of pain at 6 hours. Started Feb 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01133119.